| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 259.96B | 256.62B | 240.28B | 218.94B | 170.97B | 146.16B |
| Gross Profit | 49.26B | 49.31B | 42.05B | 32.99B | 27.74B | 22.87B |
| EBITDA | 30.10B | 32.77B | 32.05B | 27.07B | 24.77B | 21.90B |
| Net Income | 14.68B | 15.86B | 12.23B | 9.57B | 8.55B | 4.46B |
Balance Sheet | ||||||
| Total Assets | 256.84B | 246.21B | 245.00B | 210.63B | 195.36B | 175.64B |
| Cash, Cash Equivalents and Short-Term Investments | 69.76B | 68.50B | 86.14B | 57.57B | 44.63B | 40.59B |
| Total Debt | 4.24B | 5.20B | 7.66B | 7.51B | 7.75B | 8.88B |
| Total Liabilities | 58.31B | 60.76B | 58.40B | 48.50B | 46.83B | 43.65B |
| Stockholders Equity | 197.25B | 184.22B | 185.32B | 160.06B | 146.63B | 130.24B |
Cash Flow | ||||||
| Free Cash Flow | 7.95B | 13.21B | 27.01B | 13.24B | 5.60B | 7.48B |
| Operating Cash Flow | 22.39B | 27.93B | 35.38B | 21.01B | 15.46B | 12.97B |
| Investing Cash Flow | -15.24B | -25.77B | -8.72B | -10.31B | -9.63B | -8.52B |
| Financing Cash Flow | -8.69B | -14.63B | -3.53B | -3.23B | -4.20B | -3.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥166.82B | 13.70 | ― | 4.47% | 2.01% | 25.09% | |
69 Neutral | ¥204.14B | 10.65 | 7.50% | 5.39% | -2.26% | ― | |
68 Neutral | ¥572.67B | 28.26 | ― | 3.52% | 1.43% | 83.34% | |
68 Neutral | ¥207.16B | -8.32 | ― | 1.93% | -3.23% | 24.93% | |
63 Neutral | ¥561.86B | 15.03 | 3.35% | 3.18% | 0.44% | -11.36% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥1.69T | 14.23 | 8.34% | 2.03% | 4.33% | 524.86% |